| Date | Title | Description |
| 07.07.2022 | Manufacturing roundup: WuXi continues its expansion drive with another plant opening in Changzhou; Swiss biotech nets another acquisition | Thermo Fisher Scientific is headed to the Music City.
The drug manufacturer will establish a single-use technology site in Nashville, TN, which it says will be one of the largest in the world and will double the company’s single-use manufac... |
| 21.12.2021 | PharmaFluidics acquired by Thermo Fisher Scientific | November 1, 2021 - Thermo Fisher Scientific announced its acquisition of PharmaFluidics: |
| 18.11.2021 | J&J uncorks long-term data for Crohn's disease candidate; Age-related disease biotech earns Eli Lilly's backing | J&J and AbbVie are competing for the same Crohn’s disease market with their respective IL-23 drugs, Tremfya and Skyrizi. On Wednesday, J&J’s Janssen unit revealed data it thinks could prove a key differentiator but a... |
| 18.11.2021 | Hovione plots global expansion project, looking to boost capacity on both sides of the Atlantic | Hovione is going global with its manufacturing expansion, from New Jersey all the way to Portugal.
The CDMO announced last week it would put $170 million into expansions in Portugal, Ireland and NJ, in an effort to in... |
| 18.11.2021 | Covid-19 roundup: Pfizer lands massive $5B+ deal with US for potential pill; Boosters for all adults are incoming | Pfizer’s pill to treat Covid-19 is outpacing its top rival from Merck not only in terms of efficacy data but now in the size of its US government contract, too.
The US on Thursday announced it will pay $5.29 billion for 10 m... |
| 18.11.2021 | Flagship's machine learning startup Generate bags $370M in latest round with plans for a big hiring spree | As the future of machine learning and AI promises to make major breakthroughs in drug development, a suite of startups is looking to scale their own competing robot brain trusts. An ambitious startup out of Flagship Pion... |
| 18.11.2021 | An RA-backed startup 'ATACs' a novel challenge, looking to spur protein degradation outside the cell | The way BridgeBio tells it, it’s been up to some big things recently. And on Thursday, the biotech just got a whole lot more cash to turn its dreams into reality.
BridgeBio took out a $750 million loan on Thursday, separated into two tranch... |
| 18.11.2021 | Endo partners up with US government on $120M infusion into the national stockpile | Endo International is expanding its manufacturing capacity at a subsidiary to help out the US national stockpile, and it’s getting funding from the government to do so.
Par Sterile Products will expand the sterile ... |
| 18.11.2021 | Covid-19 roundup: Pfizer lands massive $5B+ deal with US for potential pill; Boosters for all adults are incoming | For most of the up-and-coming AI players in the biotech space, we’ve seen a slew of deals to utilize AI and machine learning in drug discovery and manufacturing. Companies such as Insilico and Generate — just to name two — have been bagging... |
| 18.11.2021 | Months after massive Ipsen deal, BAKX Therapeutics nets more cash for its 'Thelma and Louise' approach to cancer cell death | BAKX Therapeutics emerged from stealth in a big way back in July, striking an $852 million deal with Ipsen for its lead cancer candidate, a small molecule designed to activate the body’s natural process for programmed cell ... |
| 18.11.2021 | Covid-19 roundup: Pfizer lands massive $5B+ deal with US for potential pill; Boosters for all adults are incoming | Two big things are going on right now at Novartis that have the investor crowd on high alert.
First, CEO Vas Narasimhan has signaled he’s now ready to sell or spin off the big generics arm, Sandoz. In Big Pharma land, anything that drags on... |
| 18.11.2021 | WuXi officially opens cell and gene therapy site in Philly; Another massive manufacturing site comes to NC | A new cell and gene therapy testing facility in Philadelphia’s Navy Yard is officially opened, WuXi ATU announced Monday.
The new facility includes 140,000 square feet worth of laboratories, and will enhance the compa... |
| 18.11.2021 | South Korean drugmaker SK looks to take over Philly CDMO's operations | The holding company of a South Korean vaccine maker is in the final talks to make an investment into a US gene therapy firm.
SK Biosciences is in the process of signing a deal with the Center for Breakthrough Medicines (C... |
| 18.11.2021 | Covid-19 roundup: Pfizer lands massive $5B+ deal with US for potential pill; Boosters for all adults are incoming | Early this year researchers at Novo Nordisk were beaming as they announced the first drug identified in their RNAi alliance with Dicerna was headed into the clinic. And now they’re coming back for the whole thing.
This morning the Copenhage... |
| 18.11.2021 | Merck's Keytruda scores first win in adjuvant kidney cancer, giving it a leg up on checkpoint inhibitor rivals | Merck is making room for yet another use on its Keytruda label — this time, as the first adjuvant immunotherapy for certain renal cell carcinoma patients after they’ve had kidney surgery.
The FDA has approved Keytruda i... |
| 17.11.2021 | FDA+ roundup: ALS bill would provide $100m annually to access potential drugs; FDA needs to better enforce ClinicalTrials.gov reporting, researchers say | RBC analyst Brian Abrahams is back with an update on the death of an Alzheimer’s patient on Biogen’s controversial aducanumab, and this time he says that there are solid reasons to believe that the event was likely drug related and may have... |
| 09.11.2021 | PharmaFluidics acquired by Thermo Fisher Scientific | |
| 26.10.2021 | A Letter From Our CEO On Corporate Social Responsibility | In a world that continues to face significant health, economic, social justice and humanitarian challenges, I couldn't be prouder of Thermo Fisher's role in addressing them. We are the world leader in serving science, and our responsibility... |
| 04.10.2021 | Thermo Fisher expands into Switzerland as part of CSL collaboration | Just days after Thermo Fisher Scientific prepped to expand a St. Louis plant, the company announced it’s taking over a new, 1.5 million-square-foot site in Switzerland with plans to add 200 new employees.
The move is a part o... |
| 18.05.2021 | Microsoft's VC arm leads $21M investment in Artificial's lab automation platform | This is no fake-out—Artificial, which is developing a software platform to coordinate and automate the daily tasks of biopharma labs, has closed its series A funding round with a total of $21.5 million.
The round was led by M12, the corpora... |
| 11.03.2021 | Ani Pharma picks up generic player for a cool $210M, turbocharging its manufacturing and R&D wings | Contract manufacturing work has grown at a rapid clip the past year given demand caused in part by Covid-19. Big players are doubling down on their production footprints, and even small players are taking big swings to get in... |
| 10.03.2021 | Another SPAC is gearing up to go public, this time coming from Oleg Nodelman's EcoR1 Capital | Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
It’s another week in the biotech industry, which these days can only mean one thing: Another SPAC has filed ... |
| 10.03.2021 | AgomAb Therapeutics looks to take its 'true MET agonist' for broad use into the clinic with $74M round | Years ago, argenx reached out to Paolo Michieli, an Italian professor at the University of Torino. They wanted an expert’s help finding MET antagonists, and Michieli — who has spent more than two decades researching the bi... |
| 10.03.2021 | Arctic Vision collects $100M to bring US eye disease candidates overseas | With three eye disease candidates, in-licensed from the US, Shanghai-based Arctic Vision has hooked more than $100 million to see the therapies to the Chinese market — and possibly beyond, if CEO Eddy Wu gets his way.
Wu too... |
| 10.03.2021 | Grifols snags the rest of GigaGen in $80M acquisition; Vertex moves cutting-edge diabetes treatment into the clinic | Spain’s Grifols is putting up $80 million to buy out the 56% of equity in GigaGen it doesn’t already own.
Grifols execs touted its acquisition of a pipeline that includes “the world’s first recombinant immunoglobulin and... |
| 10.03.2021 | Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up | Gene therapy player bluebird bio ran into a big stumbling block last month when they voluntarily placed a hold on their sickle cell program in the wake of two unexpected serious adverse events, a move that was shortly followed by the FDA ma... |
| 10.03.2021 | Innovation in the clinic is picking up steam. How adaptive designs could pave the road to personalized medicine | Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to senior editors Kyle Blankenship a... |
| 10.03.2021 | Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up | A US House of Representatives subcommittee on Tuesday reignited bipartisan angst around the FDA’s drug manufacturing inspection backlog and attempts to improve its inspections process overseas.
The pandemic has forced the FDA to forgo more ... |
| 10.03.2021 | Covid-19 roundup: US lands another 100M-dose contract from J&J to back Biden's pledge; Pfizer and BioNTech could produce 3B vaccine doses next year | With headlines around the globe focused on various hitches in the global supply chain for Covid vaccines, President Joe Biden is taking out an insurance policy of sorts to help guarantee his promise to rapidly expand acc... |
| 10.03.2021 | FDA calls out Kardashian drug promo video for false claims | The FDA is clearly keeping up with the Kardashians as its Office of Prescription Drug Promotion (OPDP) raised concerns that Khloé Kardashian’s promotional video for a Biohaven Pharmaceuticals migraine drug made false cl... |
| 10.03.2021 | Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up | Intercept’s leadership has now been almost entirely hollowed out and turned over. On Wednesday, the once highly-valued biotech announced that its CFO, Sandip Kapadia, is leaving the company to “pursue another opportunity.”
Kapadia joins a m... |
| 10.03.2021 | Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up | With Covid-19 contract work growing at a rapid clip, the biggest CDMOs are taking the opportunity — and a windfall of cash — to carve out bigger footprints. At Thermo Fisher Scientific, the time’s never been better for a f... |
| 17.12.2020 | Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California | It’s been a whirlwind week for Thermo Fisher.
Over the course of five days prior to Wednesday, the Massachusetts CDMO had announced two major expansion projects across the globe, both of which will increase the company’s foo... |
| 09.12.2020 | THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific : Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test | Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test
Quantifying IgG is critical component to test population-wide vaccination effecitiveness
DARTFORD, UK - December 8, 2020 - Thermo Fisher S... |
| 09.12.2020 | Thermo Fisher Scientific : Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test | Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test
Quantifying IgG is critical component to test population-wide vaccination effecitiveness
DARTFORD, UK - December 8, 2020 - Thermo Fisher S... |
| 16.03.2020 | Thermo Fisher gets emergency use authorization for Covid-19 diagnostic | Thermo Fisher’s shares were down 6.9% on the New York Stock Exchange Monday afternoon amid a widespread plunge in stocks generally that prompted a trading halt in the morning.
“The authorization of our diagnostic test for Covid-19 will help... |
| 12.03.2020 | Thermo Fisher, J&J partner on next-generation sequencing diagnostic for cancer clinical trials | “The ability of the Oncomine Dx Target Test to rapidly detect variants of interest from very small quantities of DNA or RNA samples makes this technology ideally suited to support development programs requiring an NGS-based workflow that de... |
| 03.03.2020 | Thermo Fisher Scientific to acquire Qiagen, a maker of coronavirus diagnostics, in $11.5B deal | Shares of Qiagen were up by about 15% on the New York Stock Exchange Tuesday morning following the announcement. Thermo Fisher’s shares were up by about 4%.
“This acquisition provides us with the opportunity to leverage our industry-leading... |
| - | Here's a rundown of 23 top healthcare banker moves as firms look to staff up with talent in the red-hot space | Samantha Lee/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Healthcare investment bankers are in high demand, and many rainmakers are on the move.
Firms like SVB Leerink, JPMorga... |
| - | Thermo Fisher gets emergency use authorization for Covid-19 diagnostic | Days after a Swiss drug and diagnostics maker received a special authorization from the Food and Drug Administration for its coronavirus test, the agency has given a similar nod to another company.
Waltham, Massachusetts-based Thermo Fisher... |
| - | The Rainmakers: Meet the 20 heavyweight bankers that orchestrated the biggest deals of 2021 | From left: Naveen Nataraj, cohead of US advisory at Evercore, Anu Aiyengar, global co-head of M&A at JPMorgan, Aryeh Bourkoff, CEO and founder at LionTree Advisors, Kevin Brunner, co-head of global M&A at Bank of America LionTree Ad... |
| - | Thermo Fisher, J&J partner on next-generation sequencing diagnostic for cancer clinical trials | A unit of Johnson & Johnson is working with one of the country’s largest makers of diagnostics and lab-testing equipment to develop a companion diagnostic for cancer clinical trials.
Waltham, Massachusetts-based Thermo Fisher Scientific... |
| - | Thermo Fisher Scientific to acquire Qiagen, a maker of coronavirus diagnostics, in $11.5B deal | One of the biggest manufacturers of diagnostics technologies plans to acquire a major European diagnostics player in a deal valued at $11.5 billion.
Waltham, Massachusetts-based Thermo Fisher Scientific said Tuesday that it would acquire Ve... |
